CytoSPAR
CytoSPAR is at the forefront of transforming healthcare diagnostics for complicated Urinary Tract Infections (cUTI) with its innovative BLAST technology. This next-generation Antibiotic Susceptibility Test enables healthcare professionals to swiftly identify the most effective antibiotic treatments, enhancing patient care and outcomes. The system provides rapid, accurate results directly from urine samples in just 5 hours, significantly reducing traditional testing times and integrating seamlessly into laboratory workflows. CytoSPAR is committed to innovation in combating antibiotic resistance and improving healthcare diagnostics.
Industries
Products
Rapid bacteria-labeling antibiotic susceptibility testing system (research use)
A research-use diagnostic system that analyzes bacterial responses to antibiotics directly from urine samples to produce susceptibility profiles and MIC information in approximately 5 hours without a bacterial growth phase.
Rapid bacteria-labeling antibiotic susceptibility testing system (research use)
A research-use diagnostic system that analyzes bacterial responses to antibiotics directly from urine samples to produce susceptibility profiles and MIC information in approximately 5 hours without a bacterial growth phase.
Expertise Areas
- Phenotypic antibiotic susceptibility testing
- Direct-from-sample diagnostic assays
- UTI and complicated-UTI diagnostics
- Antimicrobial resistance testing
Key Technologies
- Bacterial labeling techniques
- Real-time bacterial response monitoring
- Phenotypic antibiotic susceptibility testing
- Direct-from-urine sample testing